Boston Scientific (BSX) Research & Development (2009 - 2026)

Boston Scientific has disclosed Research & Development across 18 years of filings, most recently posting $554.0 million for Q2 2026.

• In Q2 2026, Research & Development rose 5.32% year-over-year to $554.0 million; the TTM figure through Jun 2026 stood at $2.2 billion (up 17.33% YoY), while the FY2025 annual figure was $2.1 billion, up 27.06% from the prior year.
• Research & Development came in at $554.0 million for Q2 2026 at Boston Scientific, up from $516.0 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $569.0 million in Q4 2025 to a low of $319.0 million in Q1 2022.
• Average Research & Development over 5 years is $415.3 million, with a median of $374.5 million recorded in 2024.
• Year-over-year, Research & Development climbed 3.12% in 2022 and jumped 37.34% in 2025.
• Over 5 years, Research & Development stood at $330.0 million in 2022, then gained by 10.0% to $363.0 million in 2023, then advanced by 26.45% to $459.0 million in 2024, then advanced by 23.97% to $569.0 million in 2025, then retreated by 2.64% to $554.0 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $554.0 million in Q2 2026, $516.0 million in Q1 2026, and $569.0 million in Q4 2025.